Preclinical Characterization of BMS-791325, an Allosteric Inhibitor of Hepatitis C Virus NS5B Polymerase von LEMM, Julie A, MENGPING LIU, KNIPE, Jay O, COLONNO, Richard, MEANWELL, Nicholas A, KADOW, John F, SANTONE, Kenneth S, ROBERTS, Susan B, MIN GAO, GENTLES, Robert G, MIN DING, VOSS, Stacey, PELOSI, Lenore A, WANG, Ying-Kai, RIGAT, Karen L, MOSURE, Kathleen W, BENDER, John A

Volltext

Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor von Mosure, Kathleen W., Knipe, Jay O., Browning, Marc, Arora, Vinod, Shu, Yue-Zhong, Phillip, Thomas, Mcphee, Fiona, Scola, Paul, Balakrishnan, Anand, Soars, Matthew G., Santone, Kenneth, Sinz, Michael

Volltext

Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay von Gilibili, Ravindranath Reddy, Chatterjee, Sagnik, Bagul, Pravin, Mosure, Kathleen W, Murali, Bokka Venkata, Mariappan, T Thanga, Mandlekar, Sandhya, Lai, Yurong

Volltext

Evaluation of Cynomolgus Monkey Pregnane X Receptor, Primary Hepatocyte, and in Vivo Pharmacokinetic Changes in Predicting Human CYP3A4 Induction von Kim, Sean, Dinchuk, Joseph E, Anthony, Monique N, Orcutt, Tami, Zoeckler, Mary E, Sauer, Mary B, Mosure, Kathleen W, Vuppugalla, Ragini, Grace, Jr, James E, Simmermacher, Jean, Dulac, Heidi A, Pizzano, Jennifer, Sinz, Michael

Volltext

Phosphocholine conjugation: an unexpected in vivo conjugation pathway associated with hepatitis c ns5b inhibitors featuring a bicyclo[1.1.1]pentane von Zhuo, Xiaoliang, Cantone, Joseph L, Wang, Yingzi, Leet, John E, Drexler, Dieter M, Yeung, Kap-Sun, Huang, Xiaohua Stella, Eastman, Kyle J, Parcella, Kyle E, Mosure, Kathleen W, Soars, Matthew G, Kadow, John F, Johnson, Benjamin M

Volltext

Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay von Gilibili, Ravindranath Reddy, Chatterjee, Sagnik, Bagul, Pravin, Mosure, Kathleen W., Murali, Bokka Venkata, Mariappan, T. Thanga, Mandlekar, Sandhya, Lai, Yurong

Volltext

Nonclinical pharmacokinetics of BMS-292655, a water-soluble prodrug of the antifungal ravuconazole von Knipe, Jay O., Mosure, Kathleen W.

Volltext

Evaluation of Cynomolgus Monkey Pregnane X Receptor, Primary Hepatocyte, and in Vivo Pharmacokinetic Changes in Predicting Human CYP3A4 Inductions von KIM, Sean, DINCHUK, Joseph E, DULAC, Heidi A, PIZZANO, Jennifer, SINZ, Michael, ANTHONY, Monique N, ORCUTT, Tami, ZOECKLER, Mary E, SAUER, Mary B, MOSURE, Kathleen W, VUPPUGALLA, Ragini, GRACE, James E, SIMMERMACHER, Jean

Volltext

Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248) von MOSURE, K. W, HENDERSON, A. J, KLUNK, L. J, KNIPE, J. O

Volltext

Biaryl isoxazolinone antibacterial agents von Quesnelle, Claude A., Gill, Patrice, Roy, Stephan, Dodier, Marco, Marinier, Anne, Martel, Alain, Snyder, Lawrence B., D’Andrea, Stanley V., Bronson, Joanne J., Frosco, MaryBeth, Beaulieu, Danielle, Warr, Glen A., DenBleyker, Ken L., Stickle, Terry M., Yang, Hyekyung, Chaniewski, Susan E., Ferraro, Cheryl A., Taylor, Dennis, Russell, John W., Santone, Kenneth S., Clarke, Junius, Drain, Rebecca L., Knipe, Jay O., Mosure, Kathleen, Barrett, John F.

Volltext

Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates von TRAIL, P. A, WILLNER, D, BRASLAWSKY, G. R, BROWN, J, HOFSTEAD, S. J, GREENFIELD, R. S, FIRESTONE, R. A, MOSURE, K, KADOW, K. F, YANG, M. B, HELLSTRÖM, K. E, HELLSTRÖM, I, KNIPE, J, HENDERSON, A. J, LASCH, S. J, ZOECKLER, M. E, TRAILSMITH, M. D, DOYLE, T. W, KING, H. D, CASAZZA, A. M

Volltext